Proposal:
Applicants should submit a proposal that follows the Proposal Protocol and a budget that follows the Budget Guidelines.
The proposal can be mailed to:
CLF Medical Technology Acceleration Program, Inc.
Attn: Eliza J. Parker
747 Pierce Road
Clifton Park, NY 12065
If MTAP needs additional information to complete its review, an MTAP representative will send a letter requesting such information. If MTAP is not interested in the project, the request will be declined in writing.
MTAP will at all times seek to be fair and equitable in its dealings with investigators and their institutions. Back to Top
Application Deadline:
Proposals are reviewed on an on-going basis.
Proposal review criteria:
The criteria that research project proposals are evaluated on include:
- Existence of or potential for innovative intellectual property that provides a way to prevent, treat, or cure health problems
- Potential for scientific and commercial success
- Cost and time period of the research project
- Right to practice and ability to obtain patent protection
- Evidence of a significant enough market size for a pharmaceutical company to develop and market the technology
- Qualification of the principal investigator
Back to Top
Reasons why MTAP declines project proposals:
- Probability of scientific success is low
- Project is at a point that is too early in development
- Project development costs are too high
- Patent protection for the intellectual property cannot be obtained or the institution does not have the right to practice the invention
- Number of people infected with the disease is too few
- Commercialization potential is too low
Back to Top
|
